Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
The Annals of Thoracic Surgery|February 28, 2018
Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung AdenocarcinomaKazuki Hayasaka, Satoshi Shiono, Yuki Matsumura, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancerThomas John, Derek Kohler, Melania Pintilie, et al.Histopathology|November 21, 2013
Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinomaGhassan Allo, Bizhan Bandarchi, Naoki Yanagawa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinomaNaoki Yanagawa, Charles Leduc, Derek Kohler, et al.Thoracic Cancer|August 10, 2021
Low-grade fibromyxoid sarcoma arising from the lung: A case reportRyuichi Yoshimura, Masao Nishiya, Naoki Yanagawa, et al.AJNR. American Journal of Neuroradiology|May 24, 2024
Diagnostic Accuracy of Preoperative Quantitative Susceptibility Mapping for Detecting Histologic Intraplaque Hemorrhage in Cervical ICA Stenosis in Patients Undergoing Carotid EndarterectomyDaisuke Oomori, Yosuke Akamatsu, Ikuko Uwano, et al.Cancer Science|January 5, 2025
Comprehensive Genome Profiling-Initiated Tumor-Informed Circulating Tumor DNA Monitoring for Patients With Advanced CancerTaiga Sasaki, Hayato Hiraki, Akiko Yashima-Abo, et al.Cancer Diagnosis & Prognosis|January 12, 2023
Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case ReportArisa Machida, Daiki Ikarashi, Naoki Yanagawa, et al.Journal of Proteome Research|September 7, 2010
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signaturesYuhong Wei, Jiefei Tong, Paul Taylor, et al.JTO Clinical and Research Reports|May 16, 2022
Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLCAkira Hamada, Kenichi Suda, Toshio Fujino, et al.Pageof 12